UAB Avelit Pharma Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 0 |
| - |
| 0 |
| 0 |
| - |
| - |
| - |
| 0 |
| 0 |
| 0 |
| 0 |
| 2024 |
|---|
| 93,809 |
| 93,809 |
| 36,242 |
| 30,797 |
| 30,797 |
| 52.62 |
| 32.83 |
| 31,797 |
| 22,027 |
| 0 |
| 53,824 |
| 2025 |
|---|
| 267,740 |
| 267,740 |
| 36,426 |
| 30,233 |
| 30,233 |
| 50.93 |
| 11.29 |
| 4,383 |
| 33,754 |
| 0 |
| 38,137 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 267,740 |
| 267,740 |
| 36,426 |
| 30,233 |
| 30,233 |
| 50.93 |
| 11.29 |
| 4,383 |
| 33,754 |
| 0 |
| 38,137 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
267,740 €185 % *
Sales per employee (€)
267,740 €185 % *
Profit before tax (€)
36,426 €1 % *
Net Profit (€)
30,233 €-2 % *
Profit per employee (€)
30,233 €-2 % *
Total profitability (%)
50.93 %-3.21 % *
Net profitability (%)
11.29 %-65.61 % *
Equity (€)
4,383 €-86 % *
Amounts Payable And Liabilities (€)
33,754 €53 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
38,137 €-29 % *
